GeneOne Life Science Inc Asset Resilience Ratio

Latest as of March 2026: 0.32%

GeneOne Life Science Inc asset resilience ratio. GeneOne Life Science Inc (011000) has an Asset Resilience Ratio of 0.32% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how many days can GeneOne Life Science Inc fund operations to measure how many days the company can operate on defensive assets alone.

Liquid Assets

₩425.98 Million

≈ $288.68K USD Cash + Short-term Investments

Total Assets

₩131.29 Billion

≈ $88.97 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of GeneOne Life Science Inc (2009–2025)

Asset resilience ratio of GeneOne Life Science Inc from 2009 to 2025. This chart shows how GeneOne Life Science Inc's Asset Resilience Ratio has changed over time. Read 011000 liabilities breakdown for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down GeneOne Life Science Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see GeneOne Life Science Inc balance sheet assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩425.98 Million	0.32%
Total Liquid Assets	₩425.98 Million	0.32%

Asset Resilience Insights

Limited Liquidity: GeneOne Life Science Inc maintains only 0.32% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

GeneOne Life Science Inc Industry Peers by Asset Resilience Ratio

Compare GeneOne Life Science Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Hyloris Developmentsen Sa BR:HYL	Biotechnology	1.36%
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Oruka Therapeutics, Inc. NASDAQ:ORKA	Biotechnology	53.11%
Gempharmatech Co. Ltd. A SHG:688046	Biotechnology	23.95%
Vor Biopharma Inc NASDAQ:VOR	Biotechnology	74.48%
Inventiva S.A PA:IVA	Biotechnology	52.73%
Sunmax Biotechnology Co Ltd TWO:4728	Biotechnology	10.53%
Guangdong VTR Bio-Tech Co Ltd SHE:300381	Biotechnology	4.98%

GeneOne Life Science Inc Asset Resilience Ratio by Year (2009–2025)

GeneOne Life Science Inc asset resilience ratio by year from 2009 to 2025. The table below shows the annual Asset Resilience Ratio data for GeneOne Life Science Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	0.35%	₩415.88 Million ≈ $281.83K	₩119.21 Billion ≈ $80.78 Million	-0.03pp
2024-12-31	0.37%	₩566.19 Million ≈ $383.70K	₩151.33 Billion ≈ $102.56 Million	-0.21pp
2023-12-31	0.58%	₩877.39 Million ≈ $594.60K	₩151.01 Billion ≈ $102.34 Million	-13.93pp
2022-12-31	14.51%	₩32.34 Billion ≈ $21.92 Million	₩222.87 Billion ≈ $151.03 Million	-19.59pp
2021-12-31	34.11%	₩85.09 Billion ≈ $57.67 Million	₩249.50 Billion ≈ $169.08 Million	+13.54pp
2020-12-31	20.57%	₩28.09 Billion ≈ $19.03 Million	₩136.57 Billion ≈ $92.55 Million	+19.17pp
2019-12-31	1.39%	₩711.93 Million ≈ $482.47K	₩51.15 Billion ≈ $34.67 Million	-27.64pp
2018-12-31	29.04%	₩14.31 Billion ≈ $9.70 Million	₩49.30 Billion ≈ $33.41 Million	+5.75pp
2017-12-31	23.29%	₩10.63 Billion ≈ $7.20 Million	₩45.63 Billion ≈ $30.93 Million	-3.45pp
2016-12-31	26.74%	₩17.56 Billion ≈ $11.90 Million	₩65.66 Billion ≈ $44.50 Million	+3.08pp
2015-12-31	23.66%	₩11.28 Billion ≈ $7.65 Million	₩47.69 Billion ≈ $32.32 Million	-5.63pp
2014-12-31	29.29%	₩11.94 Billion ≈ $8.09 Million	₩40.77 Billion ≈ $27.63 Million	+20.13pp
2013-12-31	9.17%	₩2.92 Billion ≈ $1.98 Million	₩31.82 Billion ≈ $21.56 Million	-23.00pp
2012-12-31	32.16%	₩12.85 Billion ≈ $8.71 Million	₩39.96 Billion ≈ $27.08 Million	+14.48pp
2011-12-31	17.68%	₩7.15 Billion ≈ $4.85 Million	₩40.46 Billion ≈ $27.42 Million	+11.04pp
2010-12-31	6.65%	₩2.66 Billion ≈ $1.80 Million	₩40.05 Billion ≈ $27.14 Million	-27.69pp
2009-12-31	34.33%	₩20.27 Billion ≈ $13.74 Million	₩59.04 Billion ≈ $40.01 Million	--

pp = percentage points

About GeneOne Life Science Inc

KO:011000 Korea Biotechnology

Market Cap

$32.81 Million

₩48.42 Billion KRW

Market Cap Rank

#23247 Global

#1587 in Korea

Share Price

₩2670.00

Change (1 day)

+0.00%

52-Week Range

₩534.00 - ₩2670.00

All Time High

₩37651.62